Vistarin 4000 Anti-Xa IU/0.4 ml (SC Injection)
0.4 ml pre-filled syringe: ৳ 425.00
Medicine Details
Category | Details |
---|---|
Generic | Enoxaparin sodium |
Company | Aci limited |
Also available as |
Indications
- Treatment of deep vein thrombosis, with or without pulmonary embolism
- Treatment of unstable angina and non-Q-wave myocardial infarction
- Prevention of thrombus formation in extra corporeal circulation during hemodialysis
- Prophylaxis of venous thromboembolic disease in surgical patients
- Prophylaxis of venous thromboembolic disease in medical patients
Composition
- Each 0.2 ml pre-filled syringe contains Enoxaparin Sodium BP 20 mg
- Each 0.4 ml pre-filled syringe contains Enoxaparin Sodium BP 40 mg
- Each 0.6 ml pre-filled syringe contains Enoxaparin Sodium BP 60 mg
- Each 0.8 ml pre-filled syringe contains Enoxaparin Sodium BP 80 mg
Pharmacology
Low molecular weight heparin with high anti-Xa activity and low anti-IIa or antithrombin activity
Dosage
- Subcutaneously 100 anti-Xa lU/kg twice daily for 10 days
- Subcutaneously 150 anti-Xa lU/kq once daily for 10 days
- Oral anticoagulant therapy initiation
- Subcutaneously 100 anti-Xa lU/kg twice daily for 2-8 days (unstable angina and non-Q-wave myocardial infarction)
- Subcutaneously 100 anti-Xa lU/kg for patients with high risk of hemorrhage
Administration
Instructions on injecting yourself with Enoxaparin Sodium Syringes
Interaction
Recommendations for discontinuing agents affecting hemostasis prior to Vistarin therapy
Contraindications
Hypersensitivity to Enoxaparin Sodium, heparin or other low molecular weight heparins, active major bleeding
Side Effects
- Haemorrhage (bleeding)
- Thrombocytopenia
- Elevations of serum aminotransferase
- Pain, bluish marks at injection sites to skin rash at injection sites
- Neuraxial hematomas with concurrent use of Vistarin and spinal/epidural anesthesia or spinal puncture
Pregnancy & Lactation
Enoxaparin Sodium pregnancy category B, no known excretion in human milk
Precautions & Warnings
Vistarin administration precautions, platelet count monitoring recommendation
Use in Special Populations
- Dose in Elderly Patients
- Dose in Renal Impairment
- Dose in Hepatic Impairment
Overdose Effects
Neutralization of Vistarin by protamine sulfate
Therapeutic Class
Parenteral anti-coagulants
Storage Conditions
Cool and dry place, protect from light and moisture, do not store above 25°C
Related Brands
- Claxo 4000 Anti-Xa IU/0.4 ml (SC Injection) - general-pharmaceuticals-ltd
- Noxarin 8000 Anti-Xa IU/0.8 ml (SC Injection) - opsonin-pharma-ltd
- Noxarin 6000 Anti-Xa IU/0.6 ml (SC Injection) - opsonin-pharma-ltd
- Noxarin 4000 Anti-Xa IU/0.4 ml (SC Injection) - opsonin-pharma-ltd
- Noxarin 2000 Anti-Xa IU/0.2 ml (SC Injection) - opsonin-pharma-ltd